WebJan 4, 2024 · This will be the site where the Company’s research arm, Cannevert Therapeutics Ltd. will be conducting its first human study of CTL-X, a cannabis strain targeting pain management. WebProjects. Search our project database to find current and past Mitacs-funded research in your field
Seashore Organic Medicine Inc. Signs Letter of Intent with Cannevert …
WebCannevert Therapeutics Ltd Identification of medical marijuana cultivars with great potential for therapeutic application The proposed project will use classical animal models to … WebNov 28, 2024 · Veritas Pharma Inc. is an emerging-stage pharmaceutical and IP development company, who, through its 80% owned Cannevert Therapeutics Ltd. … ctn art 32
Andrew Hegle - Chief Science Officer and Director of …
WebNov 7, 2024 · Veritas Pharma Inc. is an emerging-stage pharmaceutical and IP development company, who, through Cannevert Therapeutics Ltd. ("CTL"), is advancing the science … WebOct 1, 2024 · Veritas’ CEO, Dr. Lui Franciosi stated, “With Agrima’s superior breeding and cultivating practices, our scientists at Cannevert Therapeutics Ltd. (“CTL”) will be able to further research ... WebFeb 4, 2024 · About Cannevert Therapeutics Ltd. Cannevert Therapeutics Ltd. is an Authorized analytical tester under the Cannabis Act. Date First Licensed Cannevert Therapeutics received its first cannabis licence from Health Canada on: February 4, 2024 Health Canada Cannabis Licences The following licences were issued to Cannevert … earthquakes today paicines ca